Expression of PXN is associated with adverse pathologic characteristics in hepatocellular carcinoma [28]; PXN protein level is correlated with advanced clinical stage and distant metastasis in salivary adenoid cystic carcinoma [29]; amplification of PXN is frequently observed in high risk lung cancer [17]. The gene discussed is PXN; the disease is lung cancer.